BR0112984A - Sais tartarato de derivado de tiazolidinodiona - Google Patents

Sais tartarato de derivado de tiazolidinodiona

Info

Publication number
BR0112984A
BR0112984A BR0112984-8A BR0112984A BR0112984A BR 0112984 A BR0112984 A BR 0112984A BR 0112984 A BR0112984 A BR 0112984A BR 0112984 A BR0112984 A BR 0112984A
Authority
BR
Brazil
Prior art keywords
compound
tartrate salts
thiazolidinedione derivative
derivative tartrate
salts
Prior art date
Application number
BR0112984-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Michael Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR0112984A publication Critical patent/BR0112984A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
BR0112984-8A 2000-08-04 2001-08-03 Sais tartarato de derivado de tiazolidinodiona BR0112984A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019226.0A GB0019226D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003514 WO2002012233A1 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative

Publications (1)

Publication Number Publication Date
BR0112984A true BR0112984A (pt) 2003-06-10

Family

ID=9897028

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0112984-8A BR0112984A (pt) 2000-08-04 2001-08-03 Sais tartarato de derivado de tiazolidinodiona

Country Status (23)

Country Link
EP (1) EP1307448A1 (ja)
JP (1) JP2004505971A (ja)
KR (1) KR20030022356A (ja)
CN (1) CN1458930A (ja)
AP (1) AP2003002737A0 (ja)
AU (1) AU2001276508A1 (ja)
BG (1) BG107605A (ja)
BR (1) BR0112984A (ja)
CA (1) CA2417828A1 (ja)
CZ (1) CZ2003314A3 (ja)
EA (1) EA200300231A1 (ja)
EC (1) ECSP034468A (ja)
GB (1) GB0019226D0 (ja)
HU (1) HUP0300770A2 (ja)
IL (1) IL154277A0 (ja)
MA (1) MA25830A1 (ja)
MX (1) MXPA03001086A (ja)
NO (1) NO20030508L (ja)
OA (1) OA12355A (ja)
PL (1) PL360702A1 (ja)
SK (1) SK1452003A3 (ja)
WO (1) WO2002012233A1 (ja)
ZA (1) ZA200300962B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
FR2845602B1 (fr) * 2002-10-11 2005-07-08 Servier Lab Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102532122B (zh) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 酒石酸罗格列酮的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
AU2001276508A1 (en) 2002-02-18
JP2004505971A (ja) 2004-02-26
OA12355A (en) 2004-03-19
EP1307448A1 (en) 2003-05-07
NO20030508L (no) 2003-03-20
KR20030022356A (ko) 2003-03-15
GB0019226D0 (en) 2000-09-27
SK1452003A3 (en) 2004-05-04
WO2002012233A1 (en) 2002-02-14
HUP0300770A2 (hu) 2003-11-28
PL360702A1 (en) 2004-09-20
MA25830A1 (fr) 2003-07-01
NO20030508D0 (no) 2003-01-31
CN1458930A (zh) 2003-11-26
CZ2003314A3 (cs) 2004-02-18
MXPA03001086A (es) 2003-05-27
BG107605A (bg) 2003-09-30
ZA200300962B (en) 2003-10-29
IL154277A0 (en) 2003-09-17
ECSP034468A (es) 2003-03-31
EA200300231A1 (ru) 2003-06-26
AP2003002737A0 (en) 2003-03-31
CA2417828A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
BR0108870A (pt) Sais cloridrato de 5-[4-[2-(n-metil-n-(2-piridil) amino) etoxi] benzil] tiazolidino-2,4-diona
BRPI0606768A2 (pt) forma de dosagem oral compreendendo rosiglitazona
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
BR0112981A (pt) Sais tartarato de derivado de tiazolidinadiona
BR0112984A (pt) Sais tartarato de derivado de tiazolidinodiona
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
BR0113713A (pt) Sal de cloridrato de 5-[4-[2-(metil-n-(2-piridil)amino)etóxi]benzil]tiazolidina -2,4-diona
BR0112983A (pt) Sais tartarato de derivado de tiazolidinodiona
BR0112982A (pt) Sal tartarato de derivado de tiazolidinadiona
DK1446404T3 (da) Rosiglitazonedisylater og deres anvendelse som antidiabetika
BR0111536A (pt) Sal de tiazolidinediona para tratamento de diabetes mellitus
DK1315721T3 (da) Et Thiazolidindionderivat og dets anvendelse som et antidiabetisk middel
AP1738A (en) Sodium salts of 5-[4-[2-(N-Methyl -N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
BR0111508A (pt) Iodidrato de 5-(4-(2-(n-metil-(2-piridil) amino) etóxi) benzil) tiazolidina-2,4diona como substância farmacEutica
BR0114364A (pt) Derivado de tiazolidinediona e seu uso como anti-diabético
RS50130B (sr) Farmaceutska kompozicija 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil) tiazolidin-2,4-diona
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A,5A,6AE7A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.